229 related articles for article (PubMed ID: 7537287)
1. Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia.
Klieser E; Lehmann E; Kinzler E; Wurthmann C; Heinrich K
J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):45S-51S. PubMed ID: 7537287
[TBL] [Abstract][Full Text] [Related]
2. Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double blind, randomized trial.
Heinrich K; Klieser E; Lehmann E; Kinzler E; Hruschka H
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):129-37. PubMed ID: 7509495
[TBL] [Abstract][Full Text] [Related]
3. Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial.
Huttunen MO; Piepponen T; Rantanen H; Larmo I; Nyholm R; Raitasuo V
Acta Psychiatr Scand; 1995 Apr; 91(4):271-7. PubMed ID: 7542829
[TBL] [Abstract][Full Text] [Related]
4. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY
J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
[TBL] [Abstract][Full Text] [Related]
6. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
[TBL] [Abstract][Full Text] [Related]
7. Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.
Chouinard G; Vainer JL; Bélanger MC; Turnier L; Beaudry P; Roy JY; Miller R
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1129-41. PubMed ID: 7531355
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
9. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
10. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
Dickson R; Williams R; Dalby JT
Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338
[No Abstract] [Full Text] [Related]
11. Risperidone: clinical development: north American results.
Marder SR
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():92A-93A. PubMed ID: 1379883
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of mood disorders in schizophrenia.
Azorin JM
Acta Psychiatr Scand Suppl; 1995; 388():20-3. PubMed ID: 7541599
[TBL] [Abstract][Full Text] [Related]
13. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
[TBL] [Abstract][Full Text] [Related]
14. Risperidone: clinical safety and efficacy in schizophrenia.
Borison RL; Pathiraja AP; Diamond BI; Meibach RC
Psychopharmacol Bull; 1992; 28(2):213-8. PubMed ID: 1381102
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
17. Unexpected dystonia while changing from clozapine to risperidone.
Radford JM; Brown TM; Borison RL
J Clin Psychopharmacol; 1995 Jun; 15(3):225-6. PubMed ID: 7543499
[No Abstract] [Full Text] [Related]
18. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
Carlson CD; Cavazzoni PA; Berg PH; Wei H; Beasley CM; Kane JM
J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
[TBL] [Abstract][Full Text] [Related]
19. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
Möller HJ; Pelzer E; Kissling W; Riehl T; Wernicke T
Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
